Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank91
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
29.89%
↑ 170% vs avg
Percentile
P91
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-42.93%
Historical baseline
PeriodValue
Q3 202529.89%
Q2 2025-25.81%
Q1 202512.66%
Q4 2024-30.50%
Q3 2024-27.80%
Q2 2024-6.23%
Q1 202417.21%
Q4 20235.49%
Q3 2023-9.10%
Q2 2023-12.76%
Q1 2023-7.94%
Q4 2022-11.36%
Q3 2022-14.02%
Q2 2022-371.41%
Q1 202275.63%
Q4 2021-165.45%
Q3 202159.45%
Q2 202113.74%
Q1 20212.33%
Q4 20207.74%
Q3 2020-14.88%
Q2 2020-557.11%
Q1 20200.00%
Q4 20190.00%